Free Trial

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$2.71 +0.01 (+0.37%)
Closing price 04:00 PM Eastern
Extended Trading
$2.72 +0.00 (+0.18%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLOV vs. ACT, FG, LMND, HGTY, ALHC, BWIN, PLMR, BHF, NMIH, and CS

Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Enact (ACT), F&G Annuities & Life (FG), Lemonade (LMND), Hagerty (HGTY), Alignment Healthcare (ALHC), Baldwin Insurance Group (BWIN), Palomar (PLMR), Brighthouse Financial (BHF), NMI (NMIH), and Credit Suisse Group (CS). These companies are all part of the "insurance" industry.

Clover Health Investments vs. Its Competitors

Enact (NASDAQ:ACT) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Enact has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Enact, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enact$1.20B4.36$688.07M$4.398.09
Clover Health Investments$1.37B1.01-$43.01M-$0.08-33.88

Enact has a net margin of 55.35% compared to Clover Health Investments' net margin of -2.68%. Enact's return on equity of 13.61% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Enact55.35% 13.61% 10.42%
Clover Health Investments -2.68%-12.20%-6.95%

18.0% of Enact shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 0.4% of Enact shares are held by company insiders. Comparatively, 24.1% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Enact has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500.

Clover Health Investments has a consensus price target of $4.37, indicating a potential upside of 61.13%. Given Clover Health Investments' stronger consensus rating and higher possible upside, analysts plainly believe Clover Health Investments is more favorable than Enact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enact
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Clover Health Investments
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Enact had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 7 mentions for Enact and 6 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.62 beat Enact's score of 0.09 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Enact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Enact and Clover Health Investments tied by winning 8 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.39B$2.20B$6.09B$10.54B
Dividend YieldN/AN/A5.73%4.78%
P/E Ratio-33.8839.7184.6327.10
Price / Sales1.0112.67606.05131.34
Price / CashN/A65.0637.8662.13
Price / Book3.9912.2912.246.58
Net Income-$43.01M-$65.79M$3.32B$276.75M
7 Day Performance5.86%0.97%0.76%0.91%
1 Month Performance-11.73%8.09%8.03%4.18%
1 Year Performance-35.17%31.26%71.13%35.42%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
2.6279 of 5 stars
$2.71
+0.4%
$4.37
+61.1%
-36.6%$1.39B$1.37B-33.88680
ACT
Enact
N/A$36.03
-2.0%
$35.00
-2.9%
-4.6%$5.31B$1.22B8.21500Analyst Forecast
FG
F&G Annuities & Life
3.9812 of 5 stars
$31.10
-0.1%
$43.50
+39.9%
-35.2%$4.19B$5.74B12.541,338Analyst Forecast
LMND
Lemonade
3.1266 of 5 stars
$55.99
+2.7%
$41.14
-26.5%
+148.1%$4.14B$526.50M-19.781,235News Coverage
HGTY
Hagerty
3.7465 of 5 stars
$12.08
+0.7%
$13.63
+12.8%
+6.3%$4.13B$1.20B60.381,744News Coverage
Insider Trade
Short Interest ↑
ALHC
Alignment Healthcare
2.4596 of 5 stars
$17.11
+2.9%
$18.83
+10.1%
+44.0%$3.39B$2.70B-61.101,679Analyst Forecast
Insider Trade
BWIN
Baldwin Insurance Group
3.6261 of 5 stars
$27.64
-4.0%
$43.67
+58.0%
-55.1%$3.28B$1.44B-95.314,116News Coverage
Analyst Revision
PLMR
Palomar
4.4259 of 5 stars
$112.90
-3.1%
$160.17
+41.9%
+14.9%$3.02B$553.86M19.84150Trending News
Analyst Revision
BHF
Brighthouse Financial
4.4934 of 5 stars
$51.04
-3.8%
$59.67
+16.9%
-6.2%$2.92B$4.72B5.521,400News Coverage
Analyst Forecast
NMIH
NMI
4.1328 of 5 stars
$36.40
-0.9%
$42.50
+16.8%
-14.9%$2.82B$650.97M7.73234
CS
Credit Suisse Group
N/A$0.89
flat
N/AN/A$2.77B$22.88B1.3750,480News Coverage

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners